The company had a net profit of Rs 44.61 crore for the same period in the previous fiscal, JB Chemicals & Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
As the company sold its Russia-CIS OTC business to Cilag GmbH International, a subsidiary of US-based Johnson and Johnson for Rs 754.53 crore, the results of the current quarter are not comparable with the same period previous fiscal.
30
0
765
850
1383
1599
4049
8099
14999
24999
350
999
2609
5299
1798
2166
443
599
275
0
299
599